Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats.
Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats.
复制标题
甘草酸减轻博莱霉素诱导的大鼠肺纤维化
DOI:
10.3389/fphar.2015.00215
复制
发表时间:
2015
影响因子:
5.6
通讯作者:
Wu T
中科院分区:
文献类型:
--
作者:
Gao L;Tang H;He H;Liu J;Mao J;Ji H;Lin H;Wu T
Idiopathic pulmonary fibrosis is a progressive and lethal form of interstitial lung disease that lacks effective therapies at present. Glycyrrhizic acid (GA), a natural compound extracted from a traditional Chinese herbal medicine Glycyrrhiza glabra, was recently reported to benefit lung injury and liver fibrosis in animal models, yet whether GA has a therapeutic effect on pulmonary fibrosis is unknown. In this study, we investigated the potential therapeutic effect of GA on pulmonary fibrosis in a rat model with bleomycin (BLM)-induced pulmonary fibrosis. The results indicated that GA treatment remarkably ameliorated BLM-induced pulmonary fibrosis and attenuated BLM-induced inflammation, oxidative stress, epithelial-mesenchymal transition, and activation of transforming growth factor-beta signaling pathway in the lungs. Further, we demonstrated that GA treatment inhibited proliferation of 3T6 fibroblast cells, induced cell cycle arrest and promoted apoptosis in vitro, implying that GA-mediated suppression of fibroproliferation may contribute to the anti-fibrotic effect against BLM-induced pulmonary fibrosis. In summary, our study suggests a therapeutic potential of GA in the treatment of pulmonary fibrosis.